|
Diabetes, Vol 37, Issue 6 763-772, Copyright © 1988 by American Diabetes Association
Increased hypothalamic neuropeptide Y concentrations in diabetic rat
G Williams, JH Steel, H Cardoso, MA Ghatei, YC Lee, JS Gill, JM Burrin, JM Polak and SR Bloom
Francis Fraser Laboratories, Department of Medicine, Royal Postgraduate Medical School, London, United Kingdom.
Central and lateral hypothalamic concentrations of 10 regulatory peptides
were measured by radioimmunoassay in streptozocin-induced diabetic (STZ-D)
and matched control rats between 1 day and 14 wk after diabetes induction.
After 2 wk, both central and lateral hypothalamic neuropeptide Y (NPY)
concentrations in STZ-D rats were consistently higher than those found in
control rats, with significant 30-50% increases at 4 wk in the central
hypothalamus, and at 6 and 14 wk in both central and lateral hypothalamus.
Immunocytochemical studies in 4- and 6-wk STZ-D animals showed the
appearance of intensely NPY-positive swollen cell bodies in the supraoptic
nucleus and a subjective increase in NPY staining of medial hypothalamic
nerve fibers. Central hypothalamic concentrations of three other peptides
were significantly greater in STZ-D animals than those in control animals
at single points (neurotensin, 1 day; calcitonin gene-related peptide, 2
wk; neurokinin, 4 wk). Hypothalamic concentrations of the other six
peptides examined (bombesin, galanin, neuromedin B, substance P,
somatostatin, and vasoactive intestinal peptide) did not differ
significantly between STZ-D and control groups at any time. However,
galanin immunostaining in the supraoptic and magnocellular paraventricular
nuclei was strikingly concentrated in a reduced number of distended cell
bodies. Hypothalamic peptide changes in STZ-D could be related to metabolic
disturbance, changes in energy and water balance, altered pituitary
function, or other factors. Persistently elevated concentrations of NPY, a
very potent central stimulant of eating and drinking, may mediate the
hyperphagia and polydipsia characteristic of STZ-D.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Porte Jr.
Central Regulation of Energy Homeostasis: The Key Role of Insulin
Diabetes,
December 1, 2006;
55(Supplement_2):
S155 - S160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Namkoong, M. S. Kim, P. G. Jang, S. M. Han, H. S. Park, E. H. Koh, W. J. Lee, J. Y. Kim, I. S. Park, J. Y. Park, et al.
Enhanced Hypothalamic AMP-Activated Protein Kinase Activity Contributes to Hyperphagia in Diabetic Rats
Diabetes,
January 1, 2005;
54(1):
63 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R G P Denis, C Bing, S Brocklehurst, J A Harrold, R G Vernon, and G Williams
Diurnal changes in hypothalamic neuropeptide and SOCS-3 expression: effects of lactation and relationship with serum leptin and food intake
J. Endocrinol.,
October 1, 2004;
183(1):
173 - 181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. F. Turi, Z. Liposits, S. M. Moenter, C. Fekete, and E. Hrabovszky
Origin of Neuropeptide Y-Containing Afferents to Gonadotropin-Releasing Hormone Neurons in Male Mice
Endocrinology,
November 1, 2003;
144(11):
4967 - 4974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. J. Cai, M. L. Evans, C. A. Lister, R. A. Leslie, J. R. S. Arch, S. Wilson, and G. Williams
Hypoglycemia Activates Orexin Neurons and Selectively Increases Hypothalamic Orexin-B Levels: Responses Inhibited by Feeding and Possibly Mediated by the Nucleus of the Solitary Tract
Diabetes,
January 1, 2001;
50(1):
105 - 112.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Inui
Transgenic Approach to the Study of Body Weight Regulation
Pharmacol. Rev.,
March 1, 2000;
52(1):
35 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert
Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype
Endocrinology,
September 1, 1999;
140(9):
4046 - 4055.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. Xu, P. S. Kalra, W. G. Farmerie, and S. P. Kalra
Daily Changes in Hypothalamic Gene Expression of Neuropeptide Y, Galanin, Proopiomelanocortin, and Adipocyte Leptin Gene Expression and Secretion: Effects of Food Restriction
Endocrinology,
June 1, 1999;
140(6):
2868 - 2875.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra
Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight
Endocr. Rev.,
February 1, 1999;
20(1):
68 - 100.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Bing, H. M. Frankish, L. Pickavance, Q. Wang, D. F. C. Hopkins, M. J. Stock, and G. Williams
Hyperphagia in cold-exposed rats is accompanied by decreased plasma leptin but unchanged hypothalamic NPY
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 1998;
274(1):
R62 - R68.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1988 by the American Diabetes Association.
|
|
| |
|